IDEAS home Printed from https://ideas.repec.org/e/pky20.html
   My authors  Follow this author

Margaret K. Kyle

(We have lost contact with this author. Please ask them to update the entry or send us the correct address or status for this person. Thank you.)

Personal Details

First Name:Margaret
Middle Name:K.
Last Name:Kyle
Suffix:
RePEc Short-ID:pky20
[This author has chosen not to make the email address public]
The above email address does not seem to be valid anymore. Please ask Margaret K. Kyle to update the entry or send us the correct address or status for this person. Thank you.
http://margaretkyle.net
Terminal Degree:2002 Economics Department; Massachusetts Institute of Technology (MIT) (from RePEc Genealogy)

Affiliation

Centre d'Économie Industrielle (CERNA)
Mines Paris

Paris, France
http://www.cerna.minesparis.psl.eu/
RePEc:edi:cernafr (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Software Chapters

Working papers

  1. Margaret Kyle & Omar Shah & Vivek Mani, 2024. "Hot tub time machine? What role for Towercast in EU merger control," Post-Print hal-04868687, HAL.
  2. Margaret Kyle & Sinan Corus & Julia Tanndal, 2023. "The economics of new product launches and access to pharmaceutical products in the EU: A perspective on the EC’s proposed reform of the EU pharmaceutical legislation," Post-Print hal-04351643, HAL.
  3. Margaret Kyle, 2022. "COVID-19 and clinical trials," Post-Print hal-03936125, HAL.
  4. Margaret Kyle, 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," Post-Print hal-03935839, HAL.
  5. Margaret Kyle & Vivek Mani & Sinan Corus, 2022. "Intersection of Intellectual Property and Competition Policy in Recent Cases," Post-Print hal-03935948, HAL.
  6. Andrew Elzinga & Nikhil Gupta & Margaret Kyle & Vivek Mani, 2022. "“Economic Issues in Assessing Potential and Nascent Competition”," Post-Print hal-03935872, HAL.
  7. Margaret Kyle & Anne Perrot, 2021. "Innovation pharmaceutique : comment combler le retard français ?," Post-Print hal-03150073, HAL.
  8. Margaret Kyle, 2021. "Do Patents Work? Evidence from Pharmaceutical Innovation," Post-Print hal-03519736, HAL.
  9. Margaret Kyle, 2020. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," Post-Print hal-03109956, HAL.
  10. Margaret Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," Post-Print hal-02452622, HAL.
  11. Margaret Kyle, 2019. "The Single Market in Pharmaceuticals," Post-Print hal-02055979, HAL.
  12. Margaret Kyle & Agnès Bénassy-Quéré & Olivier Blanchard & Laurence Boone & Gilberte Cette & Chiara Criscuolo & Anne Epaulard & Jean Sebastien & Xavier Ragot & Philippe Martin & Alexandra Roulet & Davi, 2019. "Productivity and competitiveness in the euro area: A view from France [Productivité et compétitivité : où en est la France dans la zone euro ?]," Post-Print hal-02452575, HAL.
  13. Arnaud Costinot & Dave Donaldson & Margaret Kyle & Heidi Williams, 2019. "The More We Die, The More We Sell? A Simple Test of the Home-Market Effect," Post-Print hal-04094236, HAL.
  14. Margaret Kyle, 2018. "Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets," Post-Print hal-01952663, HAL.
  15. Daejung Kim & Alistair Mcguire & Margaret Kyle, 2017. "Korean pharmaceutical industry policy: lessons for Korea," Working Papers hal-01952703, HAL.
  16. Kyle, Margaret, 2017. "Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets," CEPR Discussion Papers 12420, C.E.P.R. Discussion Papers.
  17. Margaret Kyle, 2017. "Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets," Working Papers hal-01952727, HAL.
  18. Kyle, Margaret & Ridley, David & Zhang, Su, 2017. "Strategic Interaction Among Governments in the Provision of a Global Public Good," CEPR Discussion Papers 12419, C.E.P.R. Discussion Papers.
  19. Dubois, Pierre & Kyle, Margaret, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality Rates," TSE Working Papers 16-688, Toulouse School of Economics (TSE).
  20. Kyle, Margaret & Dubois, Pierre, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality," CEPR Discussion Papers 11487, C.E.P.R. Discussion Papers.
  21. Margaret Kyle, 2016. "Intellectual Property Rights and Access to Innovation: Evidence from TRIPS," Working Papers hal-01448524, HAL.
  22. Margaret Kyle, 2016. "Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets," Working Papers hal-01448521, HAL.
  23. Margaret Kyle, 2016. "Study for European Commission (DG Internal Market, Industry, Entrepreneurship and SMEs) on supplementary patent certificates," Post-Print hal-01448507, HAL.
  24. Margaret Kyle, 2016. "Competition Law, Intellectual Property, and the Pharmaceutical Sector," Post-Print hal-01448506, HAL.
  25. Margaret Kyle & P. Dubois, 2016. "Estimating the Benefits of Innovation," Working Papers hal-01448523, HAL.
  26. Margaret Kyle & Heidi Williams, 2016. "Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs," Post-Print hal-01448505, HAL.
  27. Pierre Dubois & Margaret Kyle, 2016. "Estimating the Benefits of Cancer Treatments," Post-Print hal-01952710, HAL.
  28. Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016. "Competition and the Efficiency of Markets for Technology," Post-Print hal-03542108, HAL.
  29. Margaret Kyle, 2016. "Competition law, intellectual property, and the pharmaceutical sector," Post-Print hal-01514478, HAL.
  30. Margaret Kyle & D. Ridley, & S. Zhang,, 2016. "Government Free-riding in Research Funding," Working Papers hal-01448520, HAL.
  31. Margaret Kyle & Yi Qian, 2014. "Intellectual Property Rights and Access to Innovation: Evidence from TRIPS," NBER Working Papers 20799, National Bureau of Economic Research, Inc.
  32. Margaret Kyle & Qian Yi, 2014. "Intellectual property rights and access to innovation: evidence from TRIPS," Working Papers hal-01952690, HAL.
  33. Margaret Kyle & Till Barnighausen & Joshua Salomon & Brenda Waning, 2012. "Assessing the population health impact of market interventions to improve access to antiretroviral treatment," Post-Print halshs-00739081, HAL.
  34. Henry.G Grabowski & Margaret Kyle & Richard Mortimer & Genia Long & Noam Kirson, 2012. "Evolution of Market Exclusivity, Paragraph IV Challenges and Generic Penetration," Post-Print halshs-00738629, HAL.
  35. Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," SciencePo Working papers Main hal-03473787, HAL.
  36. Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in the sale of ideas: theory and empirics," SciencePo Working papers Main hal-00639128, HAL.
  37. Kyle, Margaret & Allain, Marie-Laure, 2011. "Inefficiencies in technology transfer: theory and empirics," CEPR Discussion Papers 8206, C.E.P.R. Discussion Papers.
  38. G. Grabowski Henry & Margaret Kyle & Richard Mortimer & Genia Long & Noam Kirson, 2011. "Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act," Post-Print halshs-00738443, HAL.
  39. Kyle, Margaret & McGahan, Anita M, 2011. "Investments in Pharmaceuticals Before and After TRIPS," CEPR Discussion Papers 8371, C.E.P.R. Discussion Papers.
  40. Margaret K. Kyle, 2007. "Strategic Responses to Parallel Trade," NBER Working Papers 12968, National Bureau of Economic Research, Inc.
  41. Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson, 2006. "Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research," NBER Working Papers 12509, National Bureau of Economic Research, Inc.
  42. Allen N. Berger & Margaret K. Kyle & Joseph M. Scalise, 2000. "Did U.S. bank supervisors get tougher during the credit crunch? Did they get easier during the banking boom? Did it matter to bank lending?," Finance and Economics Discussion Series 2000-39, Board of Governors of the Federal Reserve System (U.S.).

Articles

  1. Margaret K. Kyle, 2025. "Lessons for the United States from Pharmaceutical Regulation Abroad," Journal of Economic Perspectives, American Economic Association, vol. 39(2), pages 53-78, Spring.
  2. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).
  3. Margaret K. Kyle, 2020. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," Innovation Policy and the Economy, University of Chicago Press, vol. 20(1), pages 95-123.
  4. Margaret K. Kyle, 2019. "The Single Market in Pharmaceuticals," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 55(1), pages 111-135, August.
  5. Arnaud Costinot & Dave Donaldson & Margaret Kyle & Heidi Williams, 2019. "The More We Die, The More We Sell? A Simple Test of the Home-Market Effect," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 134(2), pages 843-894.
  6. Margaret K. Kyle, 2018. "Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 211-234, August.
  7. Margaret Kyle & Heidi Williams, 2017. "Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs," American Economic Review, American Economic Association, vol. 107(5), pages 486-490, May.
  8. Kyle, Margaret K. & Ridley, David B. & Zhang, Su, 2017. "Strategic interaction among governments in the provision of a global public good," Journal of Public Economics, Elsevier, vol. 156(C), pages 185-199.
  9. Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016. "Competition and the Efficiency of Markets for Technology," Management Science, INFORMS, vol. 62(4), pages 1000-1019, April.
  10. Mercedes Delgado & Margaret Kyle & Anita M. McGahan, 2013. "Intellectual Property Protection and the Geography of Trade," Journal of Industrial Economics, Wiley Blackwell, vol. 61(3), pages 733-762, September.
  11. Margaret K. Kyle & Anita M. McGahan, 2012. "Investments in Pharmaceuticals Before and After TRIPS," The Review of Economics and Statistics, MIT Press, vol. 94(4), pages 1157-1172, November.
  12. Kyle Margaret, 2011. "Strategic Responses to Parallel Trade," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 11(2), pages 1-34, January.
  13. Margaret K. Kyle, 2007. "Pharmaceutical Price Controls and Entry Strategies," The Review of Economics and Statistics, MIT Press, vol. 89(1), pages 88-99, February.
  14. Henry G. Grabowski & Margaret Kyle, 2007. "Generic competition and market exclusivity periods in pharmaceuticals," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 491-502.
  15. Glenn Pransky & Stan Finkelstein & Ernst Berndt & Margaret Kyle & Joan Mackell & Dan Tortorice, 2006. "Objective and self‐report work performance measures: a comparative analysis," International Journal of Productivity and Performance Management, Emerald Group Publishing Limited, vol. 55(5), pages 390-399, July.
  16. Margaret K. Kyle, 2006. "The role of firm characteristics in pharmaceutical product launches," RAND Journal of Economics, RAND Corporation, vol. 37(3), pages 602-618, September.
  17. Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson, 2005. "Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research," Annals of Economics and Statistics, GENES, issue 79-80, pages 165-188.
  18. Margaret K. Kyle, 2004. "Does locale affect R&D productivity? the case of pharmaceuticals," FRBSF Economic Letter, Federal Reserve Bank of San Francisco, issue nov12.
  19. Davina C. Ling & Ernst R. Berndt & Margaret K. Kyle, 2002. "Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales," Journal of Law and Economics, University of Chicago Press, vol. 45(S2), pages 691-723.

Software components

  1. Michael Gordy & Margaret Kyle, 1997. "MATLAB/C code for GIG and BNLG common value auction specifications," Matlab codes gigbnlg, .

Chapters

  1. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
  2. Scott Morton, Fiona & Kyle, Margaret, 2011. "Markets for Pharmaceutical Products11The authors thank Tom McGuire for editorial advice and improvements and participants at the Handbook conference for helpful suggestions," Handbook of Health Economics, in: Mark V. Pauly & Thomas G. Mcguire & Pedro P. Barros (ed.), Handbook of Health Economics, volume 2, chapter 0, pages 763-823, Elsevier.
  3. Jeffrey L. Furman & Margaret K. Kyle & Iain Cockburn & Rebecca M. Henderson, 2010. "Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research," NBER Chapters, in: Contributions in Memory of Zvi Griliches, pages 165-188, National Bureau of Economic Research, Inc.
  4. Henry Grabowski & Margaret Kyle, 2008. "Mergers and Alliances in Pharmaceuticals: Effects on Innovation and R&D Productivity," Chapters, in: Klaus Gugler & B. Burcin Yurtoglu (ed.), The Economics of Corporate Governance and Mergers, chapter 11, Edward Elgar Publishing.
  5. Ernst R. Berndt & Margaret Kyle & Davina Ling, 2003. "The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches," NBER Chapters, in: Scanner Data and Price Indexes, pages 229-267, National Bureau of Economic Research, Inc.
  6. Allen N. Berger & Margaret K. Kyle & Joseph M. Scalise, 2001. "Did US Bank Supervisors Get Tougher during the Credit Crunch? Did They Get Easier during the Banking Boom? Did It Matter to Bank Lending?," NBER Chapters, in: Prudential Supervision: What Works and What Doesn't, pages 301-356, National Bureau of Economic Research, Inc.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 14 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-INO: Innovation (7) 2006-09-23 2009-10-31 2011-12-05 2013-07-15 2013-07-20 2015-01-19 2017-12-03. Author is listed
  2. NEP-COM: Industrial Competition (6) 2007-03-17 2011-12-05 2013-07-15 2013-07-20 2015-01-19 2024-01-29. Author is listed
  3. NEP-IPR: Intellectual Property Rights (5) 2007-03-17 2009-10-31 2011-12-05 2013-07-15 2015-01-19. Author is listed
  4. NEP-TID: Technology and Industrial Dynamics (4) 2006-09-23 2011-12-05 2013-07-15 2013-07-20
  5. NEP-HEA: Health Economics (3) 2009-10-31 2016-09-11 2017-02-05
  6. NEP-REG: Regulation (3) 2000-05-16 2009-10-31 2024-01-29
  7. NEP-EUR: Microeconomic European Issues (2) 2016-09-11 2024-01-29
  8. NEP-HIS: Business, Economic and Financial History (2) 2000-05-16 2000-10-05
  9. NEP-IND: Industrial Organization (2) 2013-07-15 2013-07-20
  10. NEP-BEC: Business Economics (1) 2011-12-05
  11. NEP-CSE: Economics of Strategic Management (1) 2013-07-20
  12. NEP-CTA: Contract Theory and Applications (1) 2011-12-05
  13. NEP-EEC: European Economics (1) 2024-01-29
  14. NEP-EFF: Efficiency and Productivity (1) 2006-09-23
  15. NEP-GEO: Economic Geography (1) 2006-09-23
  16. NEP-GTH: Game Theory (1) 2011-12-05
  17. NEP-INT: International Trade (1) 2007-03-17
  18. NEP-KNM: Knowledge Management and Knowledge Economy (1) 2006-09-23
  19. NEP-MIC: Microeconomics (1) 2011-12-05
  20. NEP-MON: Monetary Economics (1) 2000-10-05
  21. NEP-PBE: Public Economics (1) 2017-12-03
  22. NEP-PPM: Project, Program and Portfolio Management (1) 2013-07-15
  23. NEP-PUB: Public Finance (1) 2017-12-03
  24. NEP-URE: Urban and Real Estate Economics (1) 2006-09-23

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Margaret K. Kyle should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.